GATX vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

GATX

69.0
AI Score
VS
GATX Wins

CNS

56.1
AI Score

Investment Advisor Scores

GATX

69score
Recommendation
BUY

CNS

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GATX CNS Winner
Revenue 94.41M 1.16B GATX
Net Income 29.96M 188.90M GATX
Net Margin 31.7% 16.2% CNS
ROE 9.9% 6.8% CNS
ROA 6.7% 1.1% CNS
Total Assets 450.12M 17.72B GATX
Cash 193.73M 747.10M GATX

Relative Price Performance (Last 90 Days)

GATX 1M: -9.6% · 3M: -9.7% CNS 1M: -5.7% · 3M: -12.5%

Current Technical Phase

GATX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.8%), weak momentum, RSI 43

RSI (14): 42.8 · Price: $165.73

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.5 · Price: $70.90

Fundamentals Snapshot

Metric GATX CNS
Market Cap — —
Forward P/E 14.9 19.3
Trailing P/E 16.3 21.6
Revenue (TTM) — —
Revenue Growth 0.3% 0.1%
Gross Margin 0.7% 0.5%
Operating Margin 0.3% 0.3%
EPS 10.10 3.25
Dividend Yield 0.02% 0.04%

Frequently Asked Questions

Based on our detailed analysis, GATX is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.